Our faculty are national experts in pharmacoepidemiology and conduct research to enable prescribers to make safe, informed decisions for their patients. These are active pharmacoepidemiology projects conducted by our faculty.
The Development, Validation, and Application of a Claims-based Metric of Low Value Prescribing in Older Adults
PI: Thomas R. Radomski, MD, MS
Funding Source: NIH/NIA; August 2019 - June 2024
Machine-Learning Prediction and Reducing Overdoses with EHR Nudges (mPROVEN)
PI: Walid Gellad, MD, MPH
Funding Source: NIH/NIDA; July 2022 - April 2027
Evidence-based Clinical Practice Guideline for the Management of Acute Dental Pain: Development, Implementation, and Evaluation Using Data Analytics to Target An Implementation Strategy
Co-I: Katie Suda, PharmD
Funding Source: FDA; September 2020 - August 2023
Evaluation of multiple medication exposures concurrently using a novel algorithm
PI: Ravy Vajravelu, MD, MCSE
Funding Source: NIH/NIDDK; July 1, 2019 - March 31, 2024
Access, Quality and Equity of Anticoagulants in Veterans with Atrial Fibrillation
PI: Utibe Essien, MD, MPH
Funding Source: VA; February 2021 - January 2026
Human vs. Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings: A Randomized Controlled Trial (HumAn-1)
PI: Jing Luo, MD, MPH
Funding Source: The Leona M. and Harry B. Helmsley Charitable Trust
December 2021 - November 2024
All published work in pharmacoepidemiology